 AstraZeneca stock jumped Tuesday after the company reaffirmed its plan to acquire Alexion Pharmaceuticals in the third quarter, even as more European countries suspended use of its Covid vaccine. The post AstraZeneca Pops On Alexion Buyout Despite Mounting Covid Vaccine Doubt appeared first on Investors Business Daily. 